Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Judson

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Anti-Cancer Drugs|August 1, 1997
'Tomudex' (raltitrexed) development: preclinical, phase I and II studiesI R Judson
Seminars in Oncology|December 1, 1992
The anthrapyrazoles: a new class of compounds with clinical activity in breast cancerI R Judson
Anti-Cancer Drugs|June 1, 1991
Anthrapyrazoles: true successors to the anthracyclines?I R Judson
British Journal of Cancer|August 1, 1989
New endocrine agents, guidelines for future developmentI R Judson
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Pharmacokinetic modelling--a prelude to therapeutic drug monitoring for all cancer patients?I R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Understanding anticancer drug resistance: opportunities for modulation and impact on new drug designI R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II studies: wrong doses, wrong patients?I R Judson
Cancer Chemotherapy and Pharmacology|January 1, 1985
Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimenI R Judson, E Wiltshaw
Lancet (London, England)|September 3, 1983
A near-death experienceI R Judson, E Wiltshaw
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metabolism of hexamethylmelamine in miceI R Judson, C J Rutty
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Anti-Cancer Drugs|August 1, 1997
'Tomudex' (raltitrexed) development: preclinical, phase I and II studiesI R Judson
Seminars in Oncology|December 1, 1992
The anthrapyrazoles: a new class of compounds with clinical activity in breast cancerI R Judson
Anti-Cancer Drugs|June 1, 1991
Anthrapyrazoles: true successors to the anthracyclines?I R Judson
British Journal of Cancer|August 1, 1989
New endocrine agents, guidelines for future developmentI R Judson
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Pharmacokinetic modelling--a prelude to therapeutic drug monitoring for all cancer patients?I R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Understanding anticancer drug resistance: opportunities for modulation and impact on new drug designI R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II studies: wrong doses, wrong patients?I R Judson
Cancer Chemotherapy and Pharmacology|January 1, 1985
Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimenI R Judson, E Wiltshaw
Lancet (London, England)|September 3, 1983
A near-death experienceI R Judson, E Wiltshaw
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metabolism of hexamethylmelamine in miceI R Judson, C J Rutty
Pageof 7